David Einhorn Adamis Pharmaceuticals Corp Transaction History

Greenlight Capital Inc

  • $1.97 Billion
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$0.57 - $1.23 $166,648 - $359,610
-292,366 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$0.92 - $1.18 $651,023 - $835,008
-707,634 Reduced 70.76%
292,366 $283,000
Q2 2021

Aug 16, 2021
BUY
$0.66 - $1.23 $660,000 - $1.23 Million
1,000,000 New
1,000,000 $1.1 Million

About Adamis Pharmaceuticals Corp

ADMP Quotes by TradingView
  • Ticker ADMP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 149,983,008
  • Market Cap $73.5M
  • Description
  • Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...
More about ADMP
Track David Einhorn's Portfolio

Track David Einhorn Portfolio

Follow David Einhorn (Greenlight Capital Inc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenlight Capital Inc, based on Form 13F filings with the SEC.

News

Stay updated on Greenlight Capital Inc and David Einhorn with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email